Prostate Cancer and Prostatic Diseases, Published online: 20 October 2026; doi:10.1038/s41391-026-01168-7 MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer?
Rossano Girometti, Gianluca Giannarini, Alessandro Crestani, Luca Urso. MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer?. // Prostate Cancer and Prostatic Diseases. – 2026. – DOI: 10.1038/s41391-026-01168-7. – URL: https://www.nature.com/articles/s41391-026-01168-7
Rossano Girometti, Gianluca Giannarini, Alessandro Crestani, & Luca Urso (2026). MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer?. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-026-01168-7
Rossano Girometti, et al. “MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer?.” Prostate Cancer and Prostatic Diseases, 2026. doi:10.1038/s41391-026-01168-7.
@article{Girometti2026,
title = {MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer?},
author = {Girometti, Rossano and Giannarini, Gianluca and Crestani, Alessandro and Urso, Luca},
journal = {Prostate Cancer and Prostatic Diseases},
year = {2026},
doi = {10.1038/s41391-026-01168-7},
url = {https://www.nature.com/articles/s41391-026-01168-7}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...